Terms: = Thyroid cancer AND RB1, OSRC, ENSG00000139687, 5925, RB, P06400
150 results:
1. CDK4 phosphorylation status and rational use for combining CDK4/6 and BRAF/MEK inhibition in advanced thyroid carcinomas.
Pita JM; Raspé E; Coulonval K; Decaussin-Petrucci M; Tarabichi M; Dom G; Libert F; Craciun L; Andry G; Wicquart L; Leteurtre E; Trésallet C; Marlow LA; Copland JA; Durante C; Maenhaut C; Cavaco BM; Dumont JE; Costante G; Roger PP
Front Endocrinol (Lausanne); 2023; 14():1247542. PubMed ID: 37964967
[TBL] [Abstract] [Full Text] [Related]
2. Network Pharmacology-Based Identification of Key Pharmacological Mechanism of Shen-qi-di-huang Decoction Acting on Uremia.
Zhang X; Chen XF; Chen WJ; Ding H; Zhang BX
Altern Ther Health Med; 2024 Jan; 30(1):44-50. PubMed ID: 37773677
[TBL] [Abstract] [Full Text] [Related]
3. POU2F3: A Sensitive and Specific Diagnostic Marker for Neuroendocrine-low/negative Small Cell Lung cancer.
Wang Y; Jin Y; Shen X; Zheng Q; Xue Q; Chen L; Lin Y; Li Y
Am J Surg Pathol; 2023 Sep; 47(9):1059-1066. PubMed ID: 37357936
[TBL] [Abstract] [Full Text] [Related]
4. p18INK4C and BRCA1 inhibit follicular cell proliferation and dedifferentiation in thyroid cancer.
Bai F; Liu X; Zhang X; Mao Z; Wen H; Ma J; Pei XH
Cell Cycle; 2023 Jul; 22(13):1637-1653. PubMed ID: 37345432
[TBL] [Abstract] [Full Text] [Related]
5. Targeted pharmacologic inhibition of S-phase kinase-associated protein 2 (SKP2) mediated cell cycle regulation in lung and other RB-Related cancers: A brief review of current status and future prospects.
Elahi AH; Morales CS; Xu XL; Eliades A; Patsalis PC; Abramson DH; Jhanwar SC
Adv Biol Regul; 2023 May; 88():100964. PubMed ID: 37004354
[TBL] [Abstract] [Full Text] [Related]
6. Combined treatment with
Huang S; Cui M; Wang R; Yang G; Wang N; Cui L; Ma G
Nucleosides Nucleotides Nucleic Acids; 2023; 42(9):731-742. PubMed ID: 36924446
[TBL] [Abstract] [Full Text] [Related]
7. FAK-mediated phosphorylation at Y464 regulates p85β nuclear translocation to promote tumorigenesis of ccRCC by repressing rb1 expression.
Zhang Y; He B; Zhang D; Zhang Y; Chen C; Zhang W; Yang S; Yao M; Cui G; Gu J; Wang T; Lin Z; Fan Y; Xiong Z; Hao Y
Cell Rep; 2023 Mar; 42(3):112188. PubMed ID: 36857183
[TBL] [Abstract] [Full Text] [Related]
8. Transcriptional Circuitry of NKX2-1 and SOX1 Defines an Unrecognized Lineage Subtype of Small-Cell Lung cancer.
Kong R; Patel AS; Sato T; Jiang F; Yoo S; Bao L; Sinha A; Tian Y; Fridrikh M; Liu S; Feng J; He X; Jiang J; Ma Y; Grullon K; Yang D; Powell CA; Beasley MB; Zhu J; Snyder EL; Li S; Watanabe H
Am J Respir Crit Care Med; 2022 Dec; 206(12):1480-1494. PubMed ID: 35848993
[No Abstract] [Full Text] [Related]
9. Comprehensive genetic analysis of histological components of combined small cell carcinoma.
Iida Y; Nakanishi Y; Shimizu T; Nomoto M; Nakagawa Y; Ito R; Takahashi N; Masuda S; Gon Y
Thorac Cancer; 2022 Aug; 13(16):2362-2370. PubMed ID: 35815661
[TBL] [Abstract] [Full Text] [Related]
10. "RB-reactivator screening" as a novel cell-based assay for discoveries of molecular targeting agents including the first-in-class MEK inhibitor trametinib (trade name: Mekinist).
Sakai T
Pharmacol Ther; 2022 Aug; 236():108234. PubMed ID: 35732246
[TBL] [Abstract] [Full Text] [Related]
11. ZFPM2-AS1: An Oncogenic Long Non-coding RNA in Multiple cancer Types.
Tan F
Mini Rev Med Chem; 2023; 23(1):88-98. PubMed ID: 35578882
[TBL] [Abstract] [Full Text] [Related]
12. Overview of the 2022 WHO Classification of Neuroendocrine Neoplasms.
Rindi G; Mete O; Uccella S; Basturk O; La Rosa S; Brosens LAA; Ezzat S; de Herder WW; Klimstra DS; Papotti M; Asa SL
Endocr Pathol; 2022 Mar; 33(1):115-154. PubMed ID: 35294740
[TBL] [Abstract] [Full Text] [Related]
13. Effects of
Orlandella FM; Mirabelli P; De Stefano AE; Iervolino PLC; Luciano N; D'Angelo S; Salvatore G
Oxid Med Cell Longev; 2022; 2022():6268755. PubMed ID: 35222800
[TBL] [Abstract] [Full Text] [Related]
14. RB depletion is required for the continuous growth of tumors initiated by loss of RB.
Doan A; Arand J; Gong D; Drainas AP; Shue YT; Lee MC; Zhang S; Walter DM; Chaikovsky AC; Feldser DM; Vogel H; Dow LE; Skotheim JM; Sage J
PLoS Genet; 2021 Dec; 17(12):e1009941. PubMed ID: 34879057
[TBL] [Abstract] [Full Text] [Related]
15. Correlation and agreement between superb micro-vascular imaging and contrast-enhanced ultrasound for assessing radiofrequency ablation treatment of thyroid nodules: a preliminary study.
Lan Y; Li N; Song Q; Zhang MB; Luo YK; Zhang Y
BMC Med Imaging; 2021 Nov; 21(1):175. PubMed ID: 34809604
[TBL] [Abstract] [Full Text] [Related]
16. Molecular characterization of pleomorphic liposarcomatous differentiation in malignant phyllodes tumor of the breast: A case report.
Zhou P; Zhang Q; Zhu J; Li P
Pathol Res Pract; 2021 Aug; 224():153489. PubMed ID: 34091389
[TBL] [Abstract] [Full Text] [Related]
17. TTF-1 and c-MYC-defined Phenotypes of Large Cell Neuroendocrine Carcinoma and Delta-like Protein 3 Expression for Treatment Selection.
Miyagawa-Hayashino A; Okada S; Takeda-Miyata N; Takashima Y; Yamada T; Takemura Y; Uchino J; Inoue M; Takayama K; Konishi E
Appl Immunohistochem Mol Morphol; 2021 Apr; 29(4):313-320. PubMed ID: 33031101
[TBL] [Abstract] [Full Text] [Related]
18. Resistance to cyclin-dependent kinase (CDK) 4/6 inhibitors confers cross-resistance to other CDK inhibitors but not to chemotherapeutic agents in breast cancer cells.
Ogata R; Kishino E; Saitoh W; Koike Y; Kurebayashi J
Breast Cancer; 2021 Jan; 28(1):206-215. PubMed ID: 32860163
[TBL] [Abstract] [Full Text] [Related]
19. [Analysis of the factors for the lymph node metastasis in rⅥb region of thyroid micropapillary carcinoma and the application value of intraoperative nano-carbon].
Sun Z; Zhao Z; Jiang H
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 Apr; 34(4):355-359. PubMed ID: 32842233
[No Abstract] [Full Text] [Related]
20. Circulating miRNome detection analysis reveals 537 miRNAS in plasma, 625 in extracellular vesicles and a discriminant plasma signature of 19 miRNAs in children with retinoblastoma from which 14 are also detected in corresponding primary tumors.
Castro-Magdonel BE; Orjuela M; Alvarez-Suarez DE; Camacho J; Cabrera-Muñoz L; Sadowinski-Pine S; Medina-Sanson A; Lara-Molina C; García-Vega D; Vázquez Y; Durán-Figueroa N; Orozco-Romero MJ; Hernández-Ángeles A; Ponce-Castañeda MV
PLoS One; 2020; 15(4):e0231394. PubMed ID: 32287312
[TBL] [Abstract] [Full Text] [Related]
[Next]